Medical Center And Dispensaries Based Reporting

Objectives	- To enhance reporting from the ambulatory health system - To monitor communicable diseases by time, place and person - To detect alerts and outbreaks at local level
Sources of data	- Medical centers and dispensaries of the Ministry of Public Healht MOPH - Medical centers and dispensaries of the Ministry of Social Affairs MOSA - Other governemental medical centers and dispensaries - Medical centers and dispensaries of various Non-Governemetal Organizations NGO - Field medical units
Target diseases and syndromes	- Vaccine preventable diseases: acute flaccid paralysis, measles, rubella, pertussis (whooping cough) and mumps - For other communicable diseases: acute diarrhea, bloody/dysenteric diarrhea, cholera, acute jaundice, acute respiratory infection (including flu-like illness), unexplained fever, scabies and leishmania - Others: asthma, accidents/injuries
Guidelines	Medical center and dispensaries based surveillance guideline: Ar, En
Reporting form	Weekly reporting form
Results	- Latest weekly national bulletin

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C09DA04	ANDARAN PLUS	G	Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	575,270 L.L
J01DD04	AXONE 500MG IM	G	Ceftriaxone (sodium) - 500mg	500mg	Injectable powder for solution+diluent	393,746 L.L
N02BE51	A.B.C.-COLD	G	Paracetamol - 500mg, Chlorphenamine maleate - 4mg, Phenylephrine HCl - 5mg		Tablet, film coated	534,977 L.L
R03DC03	AIRFAST	G	Montelukast (sodium) - 10mg	10mg	Tablet, film coated	802,274 L.L
C09DA04	ANDARAN PLUS	G	Irbesartan - 300mg, Hydrochlorothiazide - 25mg		Tablet, film coated	904,612 L.L
S01EE01	API-LOPROST	G	Latanoprost - 0.005%	0.005%	Drops	447,500 L.L
C09DA06	ARKANDA PLUS 16/12.5	G	Candesartan cilexetil - 16mg, Hydrochlorothiazide - 12.5mg	32mg	Tablet	854,940 L.L
A03BA01	ATROPINE	G	Atropine sulfate - 1mg/ml	1mg/ml	Injectable solution	702,149 L.L
A03BA01	ATROPINE SULFATE RENAUDIN	G	Atropine sulfate - 1mg/ml	0.1%	Injectable solution	397,777 L.L
A03BA01	ATROPINE I.V. 0.25 MG.	G	Atropine - 0.25mg/ml	0.25mg/ml	Injectable solution	2,412,129 L.L
A03BA01	ATROPINE	G	Atropine sulfate - 0.5mg/ml	0.5mg/ml	Injectable solution	680,315 L.L
L01BC07	AZACITIDINE ARROW	G	Azacitidine - 25mg/ml	25mg/ml	Injectable suspension	10,967,854 L.L
A03BA01	ATROPINE SULFATE RENAUDIN	G	Atropine sulfate - 0.5mg/ml	0.5mg	Injectable solution	385,683 L.L
L01BC07	AZACITIDINE EVER PHARMA	G	Azacitidine - 100mg/100ml	25mg/ml	Injectable powder for suspension	10,967,854 L.L
A03BA01	ATROPINE SULFATEAGUETTANT	G	Atropine - 0.1mg/ml	0.1mg/ml	Injectable solution	7,805,376 L.L
L01BC07	AZACITIDINE NEAPOLIS	G	Azacitidine - 100mg	100mg	Injectable lyophilised powder	9,401,575 L.L
L01BC07	AZACITIDINE SPC	G	Azacitidine - 100mg	100mg	Injectable powder	10,706,993 L.L
R03DC03	AIRFAST PEDIATRICS	G	Montelukast (sodium) - 4mg	4mg	Granules for solution	880,217 L.L
A03BB01	ANTIPAN	G	Hyoscine N butylbromide - 20mg/ml		Injectable solution	355,798 L.L
S01GA04	ALERJON	G	Oxymetazoline HCl -		Drops solution	528,130 L.L
A03BB01	ANTIPAN	G	Hyoscine N butylbromide - 20mg/ml		Injectable solution	2,557,140 L.L
M04AA01	ALLOPURINOL BIOGARAN	G	Allopurinol - 100mg	100mg	Tablet	107,507 L.L
M04AA01	APO-ALLOPURINOL	G	Allopurinol - 100mg	100mg	Tablet	331,929 L.L
C07BB03	ATONIUM PLUS	G	Chlortalidone - 25mg, Atenolol - 50mg		Tablet	738,473 L.L
N02CC05	ALMOVITAE	G	Almotriptan - 12.5mg	12.5mg	Tablet, film coated	1,148,985 L.L
C09DB01	AMLODIPINE/VALSARTAN ARROW	G	Amlodipine (besylate) - 5mg, Valsartan - 160mg		Tablet, coated	923,220 L.L
M04AA01	ALLOPURINOL BIOGARAN	G	Allopurinol - 300mg	300mg	Tablet	212,327 L.L
C07BB03	ATONIUM PLUS	G	Chlortalidone - 25mg, Atenolol - 100mg		Tablet	738,473 L.L
C09DB01	ARBITEN AM 5/160	G	Amlodipine - 5mg, Valsartan - 160mg		Caplet, film coated	857,372 L.L
M04AA01	ALURIC	G	Allopurinol - 300mg	300mg	Tablet, scored	175,339 L.L